Angsuman Chakraborty19 Oct 2006 09:39 am
Israeli human embryonic stem cell research is 2nd in world, with its researchers Just after the US in absolute (not per capita) numbers of publications in scientific journals up to the end of 2005 - way ahead of the UK, Korea, China, Singapore, Australia, Sweden and Canada.
The ranking was determined by German and American researchers and published in an article in the October issue of the journal Stem Cells.
Embryonic stem cells are in high demand as objects of research because of their ability to reproduce almost infinitely and to differentiate into many, if not all, cell types of the human body. Although numerous problems still remain, they are viewed as a potential source for engineering human organs and tissue to replace defective, ageing and diseased ones.
US research has been restricted because the conservative Bush administration has set limits on federal funding for such studies, allowing only existing lines to be experimented on and not permitting new embryos aborted or left over from in-vitro fertilization use to be studied (and killed).
Israel triumphed over all but one of the other 20 countries whose researchers have since 1998 published articles on hESC research in peer-reviewed journals, with 42 publications, compared to 128 by scientists in the US, 30 in the UK, 27 in Korea, 16 in China, 15 in Singapore (which was recently shamed by fabricated results from one lab that has since closed down), 13 each in Australia and Sweden, nine in Canada, five in Japan, four in the Netherlands, three each in Germany and Belgium, two each in Denmark and Finland and one each in the Czech Republic, Iran, Spain, Romania, Switzerland and Turkey. All the remaining countries produced no published hESC research at all.
Link [www.jpost.com/servlet/Satellite?cid=1159193379030&pagename=JPost%2FJPArticle%2FShowFull]
Filed under Stem Cell | Comment Below
Related?
Human embryonic stem cells (hESC) may help cure Oral DiseasesApril 6th, 2009 On April 4th, for the first time, researchers during the 87th General Session of the International Association for Dental Research, investigators from Tufts University in Boston, report on their research to optimize the potential of hESC cells to generate complex, functional multilayer tissues, such as the oral mucosa and skin, and to understand how tissue fabrication is controlled and directed. Previously it was little known about how hESC can be developed into complex, multilayer oral tissues that line the gums, cheeks, lips, but scientists at Tufts University, using the normal tissue engineering principle able to established the proof of the concept that a single, common source of pluripotent hESC could provide the multiple cell types needed to be recombined within different, but interactive, tissue compartments to generate complex, multilayer tissues.
Stem cell have large potential for human treatmentOctober 31st, 2008 Human embryonic stem cells are known for their ability to turn into most cell types of the body. Although many types of human cells have been tested as feeder layers for hESC cells, they do not support the hESC culture as well as the mouse cells.
U.S. Patents may encourage Novocell to initiate more groundbreaking stem cell research September 18th, 2008 Renowned Stem cell engineering company Novocell,Inc., yesterday announced that the U.S. Patent and Trademark Office has issued two patents related to its stem cell encapsulation technology and granted Notice of Allowance for a patent relating to the Company’s technology for the isolation of clinical-grade human embryonic stem cell (hESC) lines.
Stem Cell Reverses Malignant Melanoma in Micro-EnvironmentNovember 21st, 2005 Northwestern University researchers have demonstrated how the microenvironments of two human embryonic stem cell (hESC) lines induced metastatic melanoma cells to revert to a normal, skin cell-like type with the ability to form colonies similar to hESCs. The researchers also showed that these melanoma cells were less invasive following culture on the microenvironments of hESCs.
Scientists shed light on what makes stem cells tickAugust 7th, 2009 WASHINGTON - A team of U.S. scientists has identified phosphorylated signalling proteins in human embryonic stem cells (hESCs) studying which may help understand the mechanisms that determine whether stem cells divide or differentiate, what types of cells they become, and how to control those complex mechanisms to facilitate development of new therapies.
Researchers grow pancreatic cells succesfully from human embryonic stem cellOctober 29th, 2008 An important research, conducted by Geron scientists and collaborators at the University of Alberta, and been published online in advance of print in Cell Proliferation reveals about a successful engraftment of human embryonic stem cell (hESC) into pancreatic islet-like clusters (ILCs) in a diabetic mice. Pancreatic islet cells are the cells that normally secrete insulin in response to high levels of glucose in the blood to maintain steady levels.
How Stem Cells Do The MagicMay 28th, 2008 Human embryonic stem cells (HESC) are the cells which can transform itself into any other type of cells. This transforming ability has offered hope of producing human organs needed to replace when damaged due to injury or chronic disease.
Embryonic Stem Cell Research Heads to Close VictoryNovember 10th, 2006 Missouri voters appear to have approved a constitutional amendment Tuesday that prevents state lawmakers from banning federally authorized embryonic stem cell research and treatments. With 98 percent of the precincts reporting, 51.1 percent of the votes were cast in favor of Amendment 2 and 48.9 percent opposed it.
Leave a Comment
